Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Clin Neurol Neurosurg. 2020 Nov;198:106127. doi: 10.1016/j.clineuro.2020.106127. Epub 2020 Aug 4.
Spinal schwannoma (SS) is the most frequently diagnosed benign spinal tumor, constituting approximately 25 % of all intradural tumors. Aim of our study was to identify factors that potentially affect immediate postoperative neurological outcome, and the rate of functional recovery within 12 months.
Screening of our institutional database yielded 90 consecutive patients (mean age 57.1 years, 39 women [43.3 %]) with newly diagnosed SS between March 1997 and October 2018. We pre- and postoperatively reviewed patient charts, surgical reports, radiographic data, use of IOM, duration of symptoms, histopathology, co-morbidities, radiographic extension, surgical strategy, neurological performance (Japanese Orthopedic Association Score [JOA score] and Frankel Grade Classification).
Mean duration of preoperative symptoms was 3.6 ± 1.6 months. Most common symptoms were local pain (n = 77, 85.6 %). Macroscopic complete resection was achieved in 84 patients (93.3 %). During follow-up, complete recovery from local pain was documented for 41 patients (59.7 %), from radiating pain for 41 (69.5 %; p < 0.001). Postoperatively, 25 (27.7 %) patients developed a new neurological deficit (motor deficits n = 3 and sensory deficits n = 23; one patient developed both); after 12 months, however, motor deficits had abated in all patients, and 16 (69.5 %) patients had completely recovered from sensory deficits. Use of intraoperative monitoring (IOM) was a significant predictor for good functional outcome (p < 0.001).
Resection of SS accompanied by IOM whenever feasible should be advocated. We achieved a high number of complete resections with a low rate of morbidity. New postoperative motor or sensory deficits had a very high rate of complete recovery within 12 months.
脊髓神经鞘瘤(SS)是最常见的良性脊髓肿瘤,约占所有硬脊膜内肿瘤的 25%。本研究旨在确定可能影响术后即刻神经功能预后和 12 个月内功能恢复率的因素。
对我院数据库进行筛查,得出 1997 年 3 月至 2018 年 10 月期间连续 90 例新诊断的 SS 患者(平均年龄 57.1 岁,女性 39 例[43.3%])。我们对患者的病历、手术报告、影像学数据、术中监测(IOM)的使用、症状持续时间、组织病理学、合并症、影像学扩展、手术策略、神经功能(日本矫形协会评分[JOA 评分]和 Frankel 分级分类)进行了术前和术后回顾。
术前症状平均持续时间为 3.6±1.6 个月。最常见的症状是局部疼痛(n=77,85.6%)。84 例患者(93.3%)达到大体完全切除。随访期间,41 例患者(59.7%)局部疼痛完全缓解,41 例患者(69.5%)放射痛缓解(p<0.001)。术后,25 例(27.7%)患者出现新的神经功能缺损(运动障碍 3 例,感觉障碍 23 例;1 例同时出现两种障碍);然而,12 个月后,所有患者的运动障碍均得到缓解,16 例(69.5%)患者的感觉障碍完全恢复。术中监测(IOM)的使用是功能良好的显著预测因子(p<0.001)。
只要可行,应提倡切除 SS 并联合使用 IOM。我们实现了高比例的完全切除,发病率低。术后新发运动或感觉障碍在 12 个月内完全恢复的比例非常高。